RECRUITING

Immediate Postpartum Glucose Tolerance Testing

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Official Title

Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard

Quick Facts

Study Start:2020-09-01
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04199676

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant or recently postpartum (postpartum day 0 or 1)
  2. * ≥ 18 years of age
  3. * Gestational age ≥34 weeks
  4. * A1 or A2 gestational diabetes
  1. * Medical exclusion from completing glucose tolerance testing
  2. * Steroid administration within 10 days prior to enrollment
  3. * Chronic steroid use

Contacts and Locations

Study Contact

Kenneth Chan, MD
CONTACT
(562) 997-8510
kenneth_chan@mednax.com
Ashten Waks, MD
CONTACT
(949) 702-0704
awaks@hs.uci.edu

Principal Investigator

Kenneth Chan, MD
PRINCIPAL_INVESTIGATOR
Magella Medical Group

Study Locations (Sites)

Long Beach Memorial Medical Center/Miller Children's and Women's Hospital
Long Beach, California, 90806
United States

Collaborators and Investigators

Sponsor: MemorialCare Health System

  • Kenneth Chan, MD, PRINCIPAL_INVESTIGATOR, Magella Medical Group

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-09-01
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2020-09-01
Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • Gestational Diabetes